TABLE 2.

Molecular types and antibiotypes of 67 MRSA isolates recovered in northern Norway from 1995 to 2003

ST	MLST	CCa	SCCmec type	No. of isolates	Yr(s) of isolation	Antibiogramb	ccrc type	PFGE typed
5	1-4-1-4-12-1-10	5	I	1	2002	EDO	1	G4
5	1-4-1-4-12-1-10	5	IV	4	2001-2003	O, EO	2	G1-G3
8	3-3-1-1-4-4-3	8	IV	26e	1997-2003	FO	2	F1-F19
8	3-3-1-1-4-4-3	8	I	1	2003	FO	1	NT
12	1-3-1-8-11-5-11	12	IV	2	1995, 2002	CFO, O	2	H1-H2
22	7-6-1-5-8-8-6	22	IV	2	2002-2003	O	2	O
25	4-1-4-1-5-5-4	25	III	1	1998	O	3	K
30	2-2-2-2-6-3-2	30	IV	3	2001-2003	O	2	I1-I3
36	2-2-2-2-3-3-2	30	II	1	1996	CLEKO	2	J
39	2-2-2-2-2-2-2	30	IV	3	2003	KO, O	2	L1-L3
45	10-14-8-6-10-3-2	45	IV	4	1997-2003	FO, O	2	B1-B2, C, D
80	1-3-1-14-11-51-10	S	IV	13f	1999-2003	KSO	2	M1-M5, N
125	1-4-1-4-12-1-54	5	IV	4	2001-2002	CLEKSO, CLEKO, CKO	2	G1, G5-G7
225	1-4-1-4-12-25-10	5	II	1	2003	CLEKO	2	A1
254	3-32-1-1-4-4-3	8	IIIA	1	1997	EDKRSHOG	3	E

^aCC, clonal complex; S, singleton not assigned to any clonal complex.

^bC, ciprofloxacin; L, clindamycin; E, erythromycin; D, doxycycline; F, fusidic acid; K, kanamycin; S, streptomycin; H, chloramphenicol; O, oxacillin; G, gentamicin; R, rifampicin.

^cccr, cassette chromosome recombinase.

^dNT, not typeable.

^eAmong the 26 ST8-MRSA-IV isolates, four of the isolates were from nasal swab samples, i.e., the nursing home staff (n = 2), the hospital staff (n = 1), and from a nursing home patient (n = 1).

^fAmong the ST80-MRSA-IV isolates, two isolates were from nasal swab samples. They were from a hospital patient and an outpatient.